WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Results 1-10 of 2,212 for Criteria: Office(s):all Language:ES Stemming: true maximize
Página anterior 1 2 3 4 5 6 7 8 9 10 Página siguiente
Page: / 222  Go >
RSS icon map icon

Analysis
Analysis

List Length
No translation
NoCtrTitlePubDateInt.ClassAppl.NoApplicantInventor
1. WOWO/2013/070176 - A METHOD FOR RECYCLING WASTE THERMOPLASTIC MATERIALS AND USING THIS RECYCLED THERMOPLASTIC IN COMPOSITE MATERIAL PRODUCTION16.05.2013
C08J 11/04
PCT/TR2011/000265GUVEN, Ali HakanGUVEN, Ali Hakan
This invention is related to a method for production of high strength and low cost thermoplastic composite materials by processing and treating waste plastic materials with some minerals. The object of the invention is to embody a recycling method wherein it contains high amounts of additives and therefore composite materials with high strength properties are obtained. Another object of the invention is to embody a recycling method wherein high amounts of additives are used in the production and the machines used in the production are not damaged.

2. WOWO/2013/068875 - 2-THIOPYRIMIDINONES16.05.2013
C07D 239/56
PCT/IB2012/055949PFIZER INC.CARPINO, Philip, Albert
Myeloperoxidase inhibitors, pharmaceutical compositions containing such inhibitors and the use of such inhibitors to treat, for example, cardiovascular conditions.

3. WOWO/2013/068774 - THERAPEUTIC COMBINATION OF MEMANTINE AND BACLOFEN AND PHARMACEUTICAL COMPOSITION CONTAINING THEM16.05.2013
A61K 31/13
PCT/HU2012/000119RICHTER GEDEON NYRT.KOVÁCS, Péter
The present invention relates to the combination of memantine and baclofen active ingredients, and also to the method for achieving body weight loss and thereby treating obesity and related co-morbidities by co-administration of baclofen and memantine.

4. WOWO/2013/067141 - N- (3- { [ (3- { [2-CHLORO-5- (METHOXY) PHENYL] AMINO} QUINOXALIN- 2 -YL) AMINO] SULFONYL} PHE NYL) - 2 -METHYLALANINAMIDE AS PHOSPHATIDYLINOSITOL 3 - KINASE INHIBITOR FOR THE TREATMENT OF LYMPHOPROLIFERATIVE MALIGNANCIES10.05.2013
A61K 31/498
PCT/US2012/062999EXELIXIS, INC.DECILLIS, Arthur
Methods are provided for treating a lymphoproliferative malignancy to a patient in need of such treatment, comprising administering to the patient an effective amount of compoud A as described herein.

5. WOWO/2013/067396 - ADMINISTRATION OF NEDD8-ACTIVATING ENZYME INHIBITOR AND HYPOMETHYLATING AGENT10.05.2013
A61K 31/706
PCT/US2012/063382MILLENNIUM PHARMACEUTICALS, INC.SMITH, Peter G.
The present disclosure relates to methods for the treatment of cancer in patients in recognized need of such treatment. The methods comprise administering to such a patient an NAE inhibitor or a pharmaceutically acceptable salt thereof, such as ((1S,2S,4R)-4-(4-((1S)-2,3-dihydro-1H-inden-1-ylamino)-7H-pyrrolo[2,3 d]pyrimidin 7-yl)-2-hydroxycyclopentyl)methyl sulfamate (MLN4924) or {(1S,2S,4R)-4-[(6-{[(1R,2S)-5-chloro-2 methoxy-2,3-dihydro-1H-inden-1-yl]amino}pyrimidin-4-yl)oxy]-2-hydroxycyclopentyl}-methyl sulfamate (I-216), and a hypomethylating agent or a pharmaceutically acceptable salt thereof, such as azacitidine or decitabine. Also disclosed are medicaments for use in the treatment of cancer.

6. WOWO/2013/061205 - (4-PHENYLIMIDAZOL-2-YL) ETHYLAMINE DERIVATIVES USEFUL AS SODIUM CHANNEL MODULATORS02.05.2013
C07D 405/06
PCT/IB2012/055610PFIZER LIMITEDBAGAL, Sharanjeet Kaur
The invention relates to imidazole derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes. More particularly the invention relates to a new imidazole Nav1.8 modulators of formula (I) or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4 and R5 are as defined in the description. Nav1.8 modulators are potentially useful in the treatment of a wide range of disorders, particularly pain.

7. WOWO/2013/058409 - SUSTAINED-RELEASE PREPARATION25.04.2013
A61K 9/20
PCT/JP2012/077662TAKEDA PHARMACEUTICAL COMPANY LIMITEDTANOUE, Yutaka
Provided is a sustained-release preparation containing pioglitazone or a salt thereof as an active ingredient and showing superior sustainability. A sustained-release preparation containing pioglitazone or a salt thereof, which shows a dissolution ratio of pioglitazone of average 25-58% at the 2-hour time point, and average 60-100% at the 4-hour time point, in a dissolution test according to the 50 rpm USP Paddle Method and using pH 2.0 KC1/HC1 buffer at 37°C as a test solution.

8. WOWO/2013/055219 - UREA FINISHING METHOD18.04.2013
C07C 273/16
PCT/NL2012/050715STAMICARBON B.V.MENNEN, Johannes Henricus
Disclosed is a method for urea finishing. A urea solution is subjected to crystallization and, other than in conventional processes, the urea crystals are shaped by exerting mechanical force onto them. Thus, the conventional prilling or granulation finishing steps can be avoided, and so are the corresponding emissions of ammonia and/or dust. The crystallization comprises a flash crystallization. The invention also pertains to the urea particles obtainable by the process, to a urea plant, and to a method of modifying an existing urea plant.

9. WOWO/2013/054822 - 1 - ARYLCARBONYL - 4 - OXY - PIPERIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES18.04.2013
C07D 401/10
PCT/JP2012/076257TAKEDA PHARMACEUTICAL COMPANY LIMITEDKOIKE, Tatsuki
The present invention provides a compound useful as an agent for the prophylaxis or treatment of neurodegenerative disease and the like, or a salt thereof. The present invention relates to a compound represented by the formula (I) wherein each symbol is as defined in the specification, or a salt thereof.

10. WOWO/2013/050882 - EQUIPMENT FOR STRUCTURIZATION AND POLARIZATION OF FUEL, COMBUSTION MIXTURE OR WATER11.04.2013
F02M 27/04
PCT/IB2012/002851KUREGYAN, KamoKUREGYAN, Kamo
The invention relates to engine construction, to equipment for improving fuel and combustion mixture. Also may be used for water processing. Economy of fuel and decrease of noxious air emissions in the atmosphere are achieved. Equipment for structurization and polarization of fuel, combustion mixture or water, comprises a body in a form of a hollow cylinder with a smooth inside surface and a rod mounted in the body, both made of current-conducting materials and connectable to the electric circuit. The equipment is supplied with a battery of current-conducting discs interleaved with insulating ones, positioned on the rod. The size of a working gap for passing fuel between the tops of the discs and the body doesn't exceed 1/10 of the size of the working surface of the body. The body and the rod are made of duralumin alloy, but the current-conducting discs of aluminum. The plain surfaces of the current-conducting discs are performed with electro insulating cover, without covering the tops of the discs.


Results 1-10 of 2,212 for Criteria: Office(s):all Language:ES Stemming: true
Página anterior 1 2 3 4 5 6 7 8 9 10 Página siguiente